We are live on
!
Find out more
SELLAS Life Sciences
25 hedge funds and large institutions have $4.91M invested in SELLAS Life Sciences in 2023 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
6,973% more call options, than puts
Call options by funds: $3.18M | Put options by funds: $45K
300% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 2
75% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 4
15% more capital invested
Capital invested by funds: $4.28M → $4.91M (+$624K)
14% more funds holding
Funds holding: 22 → 25 (+3)
0.44% more ownership
Funds ownership: 10.59% → 11.03% (+0.44%)
Holders
25
Holders Change
+3
Holders Change %
+13.64%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
8
Reduced
2
Closed
4
Calls
$3.18M
Puts
$45K
Net Calls
+$3.14M
Net Calls Change
+$460K
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
T. Rowe Price Associates
Baltimore,
Maryland
| – | -$25K | -17,100 | Closed |
|
|
VFA
27
Values First Advisors
Gray,
Tennessee
| – | -$21 | -15 | Closed |
|
|
WP
28
WealthPLAN Partners
Omaha,
Nebraska
| – | -$1 | -1 | Closed |
|
29
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$307 | +191 | +96% |
|